logo

For the Inventor, By the Inventor

Kfar Manda, Israel

Peter Assaf

This inventor holds 7 USPTO granted patents. Top assignee: Renopharm Ltd.. Active years: 2007-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Assaf. Retrieved from https://idiyas.com/inventor/peter-assaf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 86(Granted Patents)


Company Filing History:

goldMedal7 out of 7 
 
Renopharm Ltd.
 patents

Years Active: 2007-2012

Loading Chart...
7 patents (USPTO):Explore Patents
1. 8134010 - Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof (2012-03-13),
2. 7968575 - Nitric oxide donors and uses thereof (2011-06-28),
3. 7579477 - Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof (2009-08-25),
4. 7498445 - Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof (2009-03-03),
5. 7368577 - Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof (2008-05-06),
6. 7332513 - Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof (2008-02-19),
7. 7189750 - Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof (2007-03-13),

Title: Innovations of Inventor Peter Assaf

Introduction

Peter Assaf is a notable inventor based in Kfar-Miilya, Israel. He has made significant contributions to the field of nitric oxide donors, with a total of 7 patents to his name. His work focuses on developing compounds that can improve medical treatments and patient outcomes.

Latest Patents

Among his latest patents are "Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof." This patent discloses novel NO-donating compounds designed to release nitric oxide in a manner that prevents or decreases the development of tolerance upon repetitive administration. The compounds result in the formation of a naturally occurring metabolite, enhancing their therapeutic potential. Another significant patent is titled "Nitric oxide donors and uses thereof," which shares similar innovative concepts and applications in the treatment of various medical conditions.

Career Highlights

Peter Assaf is currently associated with Renopharm Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating pharmaceutical compositions and medical devices that utilize his patented compounds.

Collaborations

Peter collaborates with talented individuals such as Elham Gazaleen-Mariee and Michael Naveh, contributing to a dynamic research environment that fosters innovation.

Conclusion

Peter Assaf's contributions to the field of nitric oxide donors exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…